Lorbriqua 25mg Tablet
Salt Composition
Lorlatinib (25mg)
Key Information
Short Description
Lorbriqua 25mg Tablet is used to treat adults with unresectable, advanced, or recurrent forms of non-small cell lung cancer (NSCLC) by inhibiting anaplastic lymphoma kinase (ALK).
Dosage Form
Tablet
Introduction
Lorbriqua 25mg Tablet is prescribed only to patients who no longer respond to other ALK inhibitors. It is also effective in treating ALK-positive NSCLC that has spread to the brain. Take this medicine with or without food, but preferably at the same time each day. The doctor may alter the dose or stop the treatment for a short time. Continue taking this medicine for as long as the doctor has prescribed and do not stop suddenly.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. It may be taken with or without food, but it is better to take it at a fixed time.
Safety Information
Side Effects
Edema (swelling in arms, legs, hands, and feet) Peripheral neuropathy (numbness and tingling feeling in joints, arms, and legs) Cognitive disorders (confusion, forgetfulness, and lack of concentration or attention) Breathlessness Fatigue Weight gain Joint pain Mood changes Diarrhea
Breastfeeding Warning
Pregnant or breastfeeding women should consult their doctor before taking this medicine.
Pregnancy Warning
Pregnant or breastfeeding women should consult their doctor before taking this medicine.
How it works
Lorbriqua 25mg Tablet is an anti-cancer medication that works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
